Home
>
US Stocks
>
Cerevel Therapeutics Holdings Inc
Cerevel Therapeutics Holdings Inc
CERE

Cerevel Therapeutics Holdings Inc (CERE)

$39.22.83%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$39.68
Today Low/High$39.2 / $40.72
52 Week Low/High$9 / $41.1
Market Cap$5.81B

Company Details

Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline comprising five clinical-stage investigational therapies and several pre-clinical compounds with the potential to treat a range of neuroscience diseases, including Parkinson's, epilepsy, schizophrenia and substance use disorder. Headquartered in Cambridge, Mass., Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions.
OrganisationCerevel Therapeutics Holdings Inc
Employees122
IndustryFinance

Discover more

Frequently Asked Questions

What is Cerevel Therapeutics Holdings Inc (CERE) share price today?

Can Indians buy Cerevel Therapeutics Holdings Inc (CERE) shares?

How can I buy Cerevel Therapeutics Holdings Inc (CERE) shares from India?

Can Fractional shares of Cerevel Therapeutics Holdings Inc (CERE) be purchased?

What are the documents required to start investing in Cerevel Therapeutics Holdings Inc (CERE) stocks?

We are a SEBI registered investement advisor